Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2025 ▲▼ | Q4 2025 ▲▼ | Change ▲▼ | Q3 2025 ▲▼ | Q4 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| ABIVAX Société AnonymeADS(ABVX) | 1,325,000 | 756,000 | -569,000 | $112.49M | $101.95M | 12.76% | -$10.54M |
| Dianthus Therapeutics, Inc.(DNTH) | 2,416,667 | 2,416,667 | 0 | $95.10M | $99.59M | 12.47% | +$4.50M |
| Cogent Biosciences, Inc.(COGT) | 2,874,111 | 2,350,000 | -524,111 | $41.27M | $83.47M | 10.45% | +$42.20M |
| Taysha Gene Therapies, Inc.(TSHA) | 9,067,500 | 8,859,911 | -207,589 | $29.65M | $48.73M | 6.10% | +$19.08M |
| Gossamer Bio, Inc.(GOSS) | 17,050,000 | 13,915,371 | -3,134,629 | $44.84M | $43.14M | 5.40% | -$1.70M |
| Kymera Therapeutics, Inc.(KYMR) | 360,000 | 535,000 | +175,000 | $20.38M | $41.63M | 5.21% | +$21.25M |
| ArriVent BioPharma, Inc.(AVBP) | 1,971,054 | 1,971,054 | 0 | $36.37M | $39.66M | 4.96% | +$3.29M |
| Trevi Therapeutics, Inc.(TRVI) | 2,815,000 | 2,815,000 | 0 | $25.76M | $35.24M | 4.41% | +$9.49M |
| Ocular Therapeutix, Inc.(OCUL) | 2,624,000 | 2,623,600 | -400 | $30.67M | $31.85M | 3.99% | +$1.18M |
| Mind Medicine Mindmed Inc | 2,130,000 | 2,230,000 | +100,000 | $25.11M | $29.86M | 3.74% | +$4.75M |
| Alumis Inc | 0 | 2,530,700 | +2,530,700 | $0 | $24.70M | 3.09% | +$24.70M |
| Palisade Bio, Inc.(PALI) | 0 | 9,567,898 | +9,567,898 | $0 | $22.48M | 2.81% | +$22.48M |
| Cidara Therapeutics Inc | 100,000 | 100,000 | 0 | $9.58M | $22.09M | 2.77% | +$12.51M |
| BioAge Labs, Inc.(BIOA) | 0 | 1,598,000 | +1,598,000 | $0 | $21.14M | 2.65% | +$21.14M |
| Kalvista Pharmaceuticals Inc | 1,273,333 | 1,273,333 | 0 | $15.51M | $20.56M | 2.57% | +$5.06M |
| Rapt Therapeutics Inc | 0 | 574,000 | +574,000 | $0 | $19.44M | 2.43% | +$19.44M |
| Centessa Pharmaceuticals PlcADS | 830,000 | 750,000 | -80,000 | $20.13M | $18.76M | 2.35% | -$1.37M |
| Pharvaris N V COM | 722,595 | 671,465 | -51,130 | $18.03M | $18.63M | 2.33% | +$604.4K |
| Lexeo Therapeutics, Inc.(LXEO) | 0 | 1,725,000 | +1,725,000 | $0 | $17.13M | 2.14% | +$17.13M |
| BridgeBio Oncology Therapeutics, Inc.(BBOT) | 1,043,110 | 1,043,110 | 0 | $12.08M | $13.06M | 1.63% | +$980.5K |
| DBV Technologies S.A.ADS(DBVT) | 1,018,021 | 574,200 | -443,821 | $10.18M | $11.01M | 1.38% | +$827.2K |
| Evommune, Inc.(EVMN) | 0 | 500,000 | +500,000 | $0 | $8.56M | 1.07% | +$8.56M |
| Precision BioSciences, Inc.(DTIL) | 0 | 1,917,995 | +1,917,995 | $0 | $7.98M | 1.00% | +$7.98M |
| Corbus Pharmaceuticals Holdings, Inc.(CRBP) | 1,115,000 | 955,000 | -160,000 | $14.10M | $7.77M | 0.97% | -$6.33M |
| Unicycive Therapeutics, Inc.(UNCY) | 1,000,000 | 1,000,000 | 0 | $4.36M | $5.77M | 0.72% | +$1.41M |
| PepGen Inc.(PEPG) | 700,000 | 700,000 | 0 | $3.23M | $4.56M | 0.57% | +$1.32M |
| Apellis Pharmaceuticals Inc COM | 903,500 | 0 | -903,500 | $20.45M | $0 | — | -$20.45M |
| Maze Therapeutics, Inc.(MAZE) | 177,667 | 0 | -177,667 | $4.61M | $0 | — | -$4.61M |
| Merus N V | 308,000 | 0 | -308,000 | $29.00M | $0 | — | -$29.00M |
| Neurogene Inc.(NGNE) | 252,000 | 0 | -252,000 | $4.37M | $0 | — | -$4.37M |
| Nuvation Bio Inc.CL A(NUVB) | 2,633,334 | 0 | -2,633,334 | $9.74M | $0 | — | -$9.74M |
| Nuvation Bio Inc.W EXP 02 10 202(NUVB) | 104,112 | 0 | -104,112 | $385.2K | $0 | — | -$385.2K |
| Structure Therapeutics IncADS | 115,000 | 0 | -115,000 | $3.22M | $0 | — | -$3.22M |